Episode
E17: SSRIs (Selective Serotonin Reuptake Inhibitors): Fluoxetine, Sertraline, Paroxetine, Fluvoxamine, Citalopram, Escitalopram
- Published
- Dec 4, 2024
- Duration seconds
- 5451
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/this-is-your-brain-on-drugs-psychiatry-podcast-7023342/episodes/e17-ssris-selective-serotonin-reuptake-inhibitors-fluoxetine-sertraline-paroxetine-fluvoxamine-citalopram-escitalopram/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/this-is-your-brain-on-drugs-psychiatry-podcast-7023342/e17-ssris-selective-serotonin-reuptake-inhibitors-fluoxetine-sertraline-paroxetine-fluvoxamine-citalopram-escitalopram.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
On this episode I continue with the SSRIs. In the last episode we discussed them as a class, but today I'll go over each individual SSRI and highlight the subtle differences, advantages, and disadvantages to each med. We will discuss fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), fluvoxamine (Luvox), citalopram (Celexa), and escitalopram (Lexapro). I also discuss how the placebo effect has such a strong impact on the effectiveness of these medications and how different providers exert very different boosts in effectiveness of these medications. These are meds that all docs prescribe, and they are pretty straightforward, but I think you'll learn a thing or three on this one. Have a listen!